Nipent pentostatin: Phase IV pilot data; marketed to treat hairy cell leukemia

In a U.S. Phase IV pilot study, 13 allogeneic BMT

Read the full 108 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE